INTERNATIONAL PATENT: NIKANG THERAPEUTICS, INC. FILES APPLICATION FOR "3-FLUORO-5-(((LS,2AR)-L, 3,3,4, 4-PENTAFLUORO-2A-HYDROXY-2,2A, 3,4-TETRAHYDRO-LH-CYCLOPENTA[CD]INDEN-7-YL)OXY)- BENZONITRILE DOSING REGIMEN FOR USE IN THE TREATMENT OF CANCER"

GENEVA, Nov. 18 -- NIKANG THERAPEUTICS, INC. (200 Powder Mill RoadBldg. E500Wilmington, Delaware 19803) filed a patent application (PCT/US2025/027249) for "3-FLUORO-5-(((LS,2AR)-L, 3,3,4, 4-PENTAFLUORO-2A-HYDROXY-2,2A, 3,4-TETRAHYDRO-LH-CYCLOPENTA[CD]INDEN-7-YL)OXY)- BENZONITRILE DOSING REGIMEN FOR USE IN THE TREATMENT OF CANCER" on May 01, 2025. With publication no. WO/2025/235290, the details related to the patent application was published on Nov 13, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): WANG, Keshi (c/o NiKang Therapeutics, Inc.200 Powder Mill RoadBldg. E500Wilmington, Delaware ...